ZA200700358B - Alkyl substituted indoloquinoxalines - Google Patents

Alkyl substituted indoloquinoxalines

Info

Publication number
ZA200700358B
ZA200700358B ZA200700358A ZA200700358A ZA200700358B ZA 200700358 B ZA200700358 B ZA 200700358B ZA 200700358 A ZA200700358 A ZA 200700358A ZA 200700358 A ZA200700358 A ZA 200700358A ZA 200700358 B ZA200700358 B ZA 200700358B
Authority
ZA
South Africa
Prior art keywords
lower alkyl
alkyl
alkyl substituted
similar
indoloquinoxalines
Prior art date
Application number
ZA200700358A
Other languages
English (en)
Inventor
Bergman Jan
Engqvist Robert
Gerdin Bengt
Kihlstrom Ingemar
Bjorklund Ulf
Original Assignee
Oxypharmaab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxypharmaab filed Critical Oxypharmaab
Publication of ZA200700358B publication Critical patent/ZA200700358B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
ZA200700358A 2004-06-17 2005-05-18 Alkyl substituted indoloquinoxalines ZA200700358B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401555A SE527639C2 (sv) 2004-06-17 2004-06-17 Alkylsubstituerade indolokinoxaliner

Publications (1)

Publication Number Publication Date
ZA200700358B true ZA200700358B (en) 2008-07-30

Family

ID=32710074

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700358A ZA200700358B (en) 2004-06-17 2005-05-18 Alkyl substituted indoloquinoxalines

Country Status (23)

Country Link
US (2) US7589093B2 (xx)
EP (1) EP1756111B1 (xx)
JP (1) JP5038891B2 (xx)
CN (1) CN1976934B (xx)
AT (1) ATE462707T1 (xx)
AU (1) AU2005254919B2 (xx)
BR (1) BRPI0512086A (xx)
CA (1) CA2568592C (xx)
CY (1) CY1110145T1 (xx)
DE (1) DE602005020283D1 (xx)
DK (1) DK1756111T3 (xx)
ES (1) ES2342946T3 (xx)
IL (1) IL179171A (xx)
MX (1) MXPA06014170A (xx)
NO (1) NO20070289L (xx)
NZ (1) NZ551780A (xx)
PL (1) PL1756111T3 (xx)
PT (1) PT1756111E (xx)
RU (1) RU2369609C2 (xx)
SE (1) SE527639C2 (xx)
SI (1) SI1756111T1 (xx)
WO (1) WO2005123741A1 (xx)
ZA (1) ZA200700358B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE529777C2 (sv) * 2006-01-23 2007-11-20 Vironova Ab Nya föreningar och användning därav
JP5454750B2 (ja) 2008-03-05 2014-03-26 東洋製罐株式会社 缶詰の内圧検査方法及びその装置
EP2128160B1 (en) 2008-04-30 2010-07-14 Universität Duisburg-Essen Indolo[2,3-b]-, Indeno[1,2-b]- and Indeno[2,1-b]pyrido[2,3-f] quinoxaline-3-carboxylic acids and esters, processes for their preparation and their use as antiviral, antibiotic and antitumor agents
EP2489354A1 (en) 2011-02-18 2012-08-22 Vironova AB Pharmaceutical formulation of B220 for topical treatment of herpes
CN103211960B (zh) * 2012-01-18 2017-10-13 金士力佳友(天津)有限公司 具有降血糖作用的中药组合物、其应用及制备方法
US20160031889A1 (en) * 2013-03-15 2016-02-04 Vironova Herpes Ab Antiviral indolo[2,3-b]quinoxaline
CA3181637A1 (en) * 2020-06-10 2021-12-16 Ulf Bjorklund Method for preparing a crystalline form of rabeximod
WO2021250196A1 (en) 2020-06-10 2021-12-16 Cyxone Ab New use of rabeximod
AU2021344650A1 (en) 2020-09-21 2023-05-18 Vironova Medical Ab Thionoester-derivative of rabeximod for the treatment of inflammatory and autoimmune disorders
US11643415B1 (en) 2021-12-09 2023-05-09 Cyxone Ab Rabeximod compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE504862C2 (sv) 1994-12-27 1997-05-20 Leif J I Lundblad Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler
US6333327B2 (en) 2000-02-18 2001-12-25 Leif J. I. Lundblad Method for the treatment of Multiple Sclerosis
SE516067C2 (sv) * 2000-02-18 2001-11-12 Lundblad Leif J I Användning av en förening för framställning av ett läkemedel

Also Published As

Publication number Publication date
AU2005254919B2 (en) 2011-07-21
IL179171A0 (en) 2007-03-08
SE527639C2 (sv) 2006-05-02
CA2568592C (en) 2012-10-30
ES2342946T3 (es) 2010-07-19
US7589093B2 (en) 2009-09-15
RU2369609C2 (ru) 2009-10-10
US20100009999A1 (en) 2010-01-14
IL179171A (en) 2012-12-31
PL1756111T3 (pl) 2010-08-31
ATE462707T1 (de) 2010-04-15
DE602005020283D1 (de) 2010-05-12
EP1756111B1 (en) 2010-03-31
SE0401555D0 (sv) 2004-06-17
NO20070289L (no) 2007-01-16
US20050288296A1 (en) 2005-12-29
MXPA06014170A (es) 2007-05-09
PT1756111E (pt) 2010-06-01
CN1976934A (zh) 2007-06-06
JP2008502676A (ja) 2008-01-31
US8084453B2 (en) 2011-12-27
AU2005254919A1 (en) 2005-12-29
RU2007101497A (ru) 2008-07-27
CY1110145T1 (el) 2015-01-14
WO2005123741A1 (en) 2005-12-29
CN1976934B (zh) 2013-05-29
EP1756111A1 (en) 2007-02-28
CA2568592A1 (en) 2005-12-29
DK1756111T3 (da) 2010-07-12
JP5038891B2 (ja) 2012-10-03
SI1756111T1 (sl) 2010-08-31
NZ551780A (en) 2010-05-28
BRPI0512086A (pt) 2008-02-06
US20110086859A9 (en) 2011-04-14
SE0401555L (sv) 2005-12-18

Similar Documents

Publication Publication Date Title
IL179171A0 (en) Alkyl substituted indoloquinoxalines
RS20090249A (xx) Spiroketon inhibitori acetil-coa karboksilaze
HK1068334A1 (en) Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments
ATE471323T1 (de) Purinderivate als antagonisten an purinergen rezeptoren
ATE453639T1 (de) Phenylsubstituierte pyrimidinverbindungen zur verwendung als kinasehemmer
TW200745032A (en) Novel heterobicyclic derivatives
RS92004A (xx) Pirolo-triazin anilinska jedinjenja, korisna kao inhibitori kinaze
MXPA06012595A (es) Analogos de amino-tetrazoles y metodos de uso.
WO2003106428A8 (fr) Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
MXPA05010652A (es) Pirazoles sustituidos.
ATE553106T1 (de) Heteroarylpyrrolopyridinone als kinaseinhibitoren
AP2002002578A0 (en) Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses.
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
TW200607808A (en) Pyrido-pyrimidine derivatives, preparation thereof and application thereof
TW200503712A (en) (2-carboxamido)(3-amino)thiophene compounds
TW200635594A (en) Phenyl-piperazin methanone derivatives
TW200714593A (en) Agent for treatment of solid tumor
MY136824A (en) Substituted benzoxazinones and uses thereof
TW200720265A (en) Agent for treatment of hematopoietic tumor
MXPA05010651A (es) Compuestos de pirazol.
MXPA05010650A (es) Pirazoles sustituidos.
RS20050445A (xx) Derivati morfolina koji se upotrebljavaju kao agonisti dopamina u tretmanu i.a.seksualne disfunkcije
TW200602046A (en) Pharmaceutical compounds